Quadruple and Triple Screen Test: Assessing the Risk of Birth Defects During Pregnancy
Quadruple and triple marker screen test is a
blood test conducted during pregnancy which determines if the baby is at risk of
birth defects. These tests are done at the second trimester of the pregnancy, which is performed between the 15th and 20th
weeks of pregnancy, but more accurate results can be achieved between the 16th
and 18th weeks. The triple marker test is used to assess the levels of three substances
in a pregnant woman's blood. Whereas the quadruple marker test assesses four
substances. Women over the age of 35 and having a history of birth defects should
consider getting these tests done.
Why are the Tests Performed?
The purpose
of the tests is to determine the baby's risk for specific birth defects such as
genetic disorders or chromosomal abnormalities. These tests are screening tests,
and they check only the risk. They do not diagnose the problem, and a positive
result means you need further testing. To determine the chance of having a
birth defect, certain factors are considered:
· Your age
· Family history
· Your weight
· Baby’s gestational age
What are Triple and Quadruple Marker Screen
Tests?
Triple Marker Test
·
Alpha-Fetoprotein
(AFP): AFP is produced by the foetus's liver. If the test shows
a high level of AFP, it could mean the foetus has a spinal defect or the foetal
brain, reduced skull development (anencephaly), or you are expecting multiple
births. Low AFP could mean there’s a higher risk of the foetus having Down or
Edwards syndrome.
·
Human
Chorionic Gonadotropin (HCG): The placenta produces the HCG hormone, which
is typically detected in urine and blood tests to confirm the pregnancy. High
levels of hCG mean an increased risk of the foetus having Down Syndrome.
·
Unconjugated
Estriol: It is a form of the hormone estrogen produced by the foetus and
placenta. Low levels indicate a higher risk of steroid sulfate, Down Syndrome,
or a rare and severe disorder known as Smith-Lemli-Opitz syndrome (SLOS).
Quadruple Marker
Test
The test measures
four hormones related to pregnancy, three including the triple marker test AFP,
HCG, and unconjugated estriol, and the fourth, inhibin-A.
·
Inhibin-A: It is a
protein produced by the ovaries and the placenta. If Inhibin-a levels are
higher than expected, the risk of having a baby with Down Syndrome increases
significantly.
The triple and quadruple marker test prices are quite affordable. They are an essential
prenatal screening tool that helps assess the risk of certain birth defects in
a foetus. Women over the age of 35, those with a family history of birth
defects, or those with other risk factors should consider taking these tests as
part of their prenatal care. Beyond prenatal tests, Max Lab also offers a
holistic full body checkup in Bhubaneswar designed for women’s unique health needs—whether
you’re planning a pregnancy, currently expecting, or focusing on long-term
wellness. From hormonal panels to metabolic and organ function tests, our
comprehensive packages give you a complete picture of your health.
Comments
Post a Comment